Targeted Delivery of Antisense Oligonucleotide and siRNA into Lung Cancer Cells

被引:0
|
作者
Li, Shyh-Dar [1 ]
Huang, Leaf [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA
关键词
D O I
10.1016/j.ymthe.2006.08.794
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
715
引用
收藏
页码:S276 / S276
页数:1
相关论文
共 50 条
  • [31] siRNA and targeted delivery systems in breast cancer therapy
    Mirzaei, Sepideh
    Paskeh, Mahshid Deldar Abad
    Entezari, Maliheh
    Bidooki, Seyed Hesamoddin
    Ghaleh, Vahideh Javadian
    Rezaei, Shamin
    Hejazi, Elahe Sadat
    Kakavand, Amirabbas
    Behroozaghdam, Mitra
    Movafagh, Abolfazl
    Taheriazam, Afshin
    Hashemi, Mehrdad
    Samarghandian, Saeed
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05): : 1167 - 1188
  • [32] siRNA and targeted delivery systems in breast cancer therapy
    Sepideh Mirzaei
    Mahshid Deldar Abad Paskeh
    Maliheh Entezari
    Seyed Hesamoddin Bidooki
    Vahideh Javadian Ghaleh
    Shamin rezaei
    Elahe Sadat Hejazi
    Amirabbas Kakavand
    Mitra Behroozaghdam
    Abolfazl Movafagh
    Afshin Taheriazam
    Mehrdad Hashemi
    Saeed Samarghandian
    Clinical and Translational Oncology, 2023, 25 : 1167 - 1188
  • [33] Oral delivery of siRNA and antisense oligonucleotides
    Akhtar, Saghir
    JOURNAL OF DRUG TARGETING, 2009, 17 (07) : 491 - 495
  • [34] Polymersome delivery of siRNA and antisense oligonucleotides
    Kim, Younghoon
    Tewari, Manorama
    Pajerowski, J. David
    Cai, Shenshen
    Sen, Shamik
    Williams, Jason
    Sirsi, Shashank
    Lutz, Gordon
    Discher, Dennis E.
    JOURNAL OF CONTROLLED RELEASE, 2009, 134 (02) : 132 - 140
  • [35] Polymersome delivery of siRNA and antisense oligonucleotides
    Discher, Dennis E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [36] Artificial primary-miRNAs as a platform for simultaneous delivery of siRNA and antisense oligonucleotide for multimodal gene regulation
    Kim, Hyunsook
    Jang, Bora
    Lee, Dayoung
    Kwon, S. Chul
    Lee, Hyukjin
    JOURNAL OF CONTROLLED RELEASE, 2022, 349 : 983 - 991
  • [37] The evaluation of novel cationic peptides as delivery systems for antisense oligonucleotide and siRNA gene silencing nucleic acids
    Gilmore, I.
    Owens, S.
    Mrsny, R.
    Akhtar, S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S24 - S24
  • [38] Comparison of Three Techniques for Generation of Tolerogenic Dendritic Cells: siRNA, Oligonucleotide Antisense, and Antibody Blocking
    Karimi, Mohammad Hossein
    Ebadi, Padideh
    Pourfathollah, Ali Akbar
    Moazzeni, Mohammad
    Soheili, Zahra Soheila
    Samiee, Shahram
    HYBRIDOMA, 2010, 29 (06): : 473 - 480
  • [39] HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents
    Rait, AS
    Pirollo, KF
    Ulick, D
    Cullen, K
    Chang, EH
    THERAPEUTIC OLIGONUCLEOTIDES: ANTISENSE, RNAI, TRIPLE-HELIX, GENE REPAIR, ENHANCER DECOYS, CPG AND DNA CHIPS, 2003, 1002 : 78 - 89
  • [40] Antisense oligonucleotide therapy in cancer
    Stephens, AC
    Rivers, RPA
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (02) : 118 - 122